Workplace health: long-term sickness absence and capability to work
NICE published this final guideline on the NICE website. You can also find the supporting evidence, tools and resources as well as all the stakeholder comments NICE received during consultation and the responses to these comments.
The recommendations from this guideline have been included in the NICE Pathway on Managing long-term sickness absence and capability to work, which brings together everything NICE said on Workplace health: long-term sickness absence and capability to work in an interactive flowchart.…
Read more of this article
Medical Devices Regulation from 2020
by Jenny Brodie, Senior Communications & Brand Officer, NASS
Guest blog by Dr Alison Giles, Associate Director for Healthy Ageing, Centre for Ageing Better and Public Health England; and Elaine Rashbrook, Consultant Specialist, Life Course, Public Health England.
October saw the launch of a new National Academy for Social Prescribing (NASP), to champion social prescribing and the work of local communities in connecting people for wellbeing. Its objectives include exploring new ways of sourcing statutory and non-statutory funding and brokering relationships between different sectors. Given the prevalence of MSK conditions, it is important that social prescribing has something to offer for MSK.
Bone and Joint Week in October helps get people thinking about one of the most widespread and pressing health issues of our times – musculoskeletal health and the role each person in improving it. This year ARMA’s member organisations, Public Health England, NHE England, NHS Confederation and many other organisations collaborated during the campaign using
ARMA joins Public Health England and the Centre for Ageing Better to make England the best place to grow old, because musculoskeletal health is vital to healthy ageing.
In September, Public Health England published a report on their review of the scale, distribution and causes of prescription drug dependence, and what might be done to address it. This included findings on opioid use for non cancer pain. The report made recommendations for action to reduce the problems caused by dependency and stated that effective, personalised care should include shared decision-making with patients and regular reviews of whether treatment is working.